Literature DB >> 16899532

Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey.

M R Stanford1, H K Tan, R E Gilbert.   

Abstract

AIM: To compare the clinical findings in children with symptomatic toxoplasmic ocular lesions attributable to infection acquired before or after birth.
METHODS: Cases were prospectively ascertained for 24 months through national surveillance units and reference laboratories in the British Isles. Age and presenting symptoms, site of lesion and visual impairment in children who were classified as acquiring infection either before or after birth on the basis of clinical and serological findings were compared.
RESULTS: 31 children had toxoplasmic retinochoroiditis, 15 had congenital infection and all but three of these presented before the age of 4 years. The remaining 16 children acquired toxoplasmosis postnatally, and 14 of 16 presented after the age of 10 years. A further four children had retinochoroiditis due to other causes. The presence of bilateral, multiple or posterior pole lesions did not distinguish between the two groups, but most children (16/19; 84%) presenting with acute ocular symptoms had postnatally acquired infection. Unilateral visual impairment (Snellen < or =6/18) was equally prevalent in the two groups (4/9 before birth v 7/16 after birth; p>0.5). Only two children had bilateral visual impairment, both of whom had congenital infection. No child was blind.
CONCLUSIONS: About 50% of children with ocular lesions due to toxoplasmosis had postnatal infection. Retinochoroidal lesions due to infection before and after birth were indistinguishable. The prognosis for bilateral visual function was good, regardless of when infection was acquired.

Entities:  

Mesh:

Year:  2006        PMID: 16899532      PMCID: PMC1857523          DOI: 10.1136/bjo.2005.083543

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

1.  Is ocular toxoplasmosis caused by prenatal or postnatal infection?

Authors:  R E Gilbert; M R Stanford
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.

Authors:  L Gras; R E Gilbert; A E Ades; D T Dunn
Journal:  Int J Epidemiol       Date:  2001-12       Impact factor: 7.196

3.  Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications.

Authors:  R E Gilbert; D T Dunn; S Lightman; P I Murray; C E Pavesio; P D Gormley; J Masters; S P Parker; M R Stanford
Journal:  Epidemiol Infect       Date:  1999-10       Impact factor: 2.451

4.  Ocular toxoplasmosis: clinical features and prognosis of 154 patients.

Authors:  Lotje E H Bosch-Driessen; Tos T J M Berendschot; Jenny V Ongkosuwito; Aniki Rothova
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

5.  Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth.

Authors:  K Freeman; L Oakley; A Pollak; W Buffolano; E Petersen; A E Semprini; A Salt; R Gilbert
Journal:  BJOG       Date:  2005-01       Impact factor: 6.531

Review 6.  Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?

Authors:  R E Gilbert; C S Peckham
Journal:  J Med Screen       Date:  2002       Impact factor: 2.136

7.  Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.

Authors:  R Gilbert; L Gras
Journal:  BJOG       Date:  2003-02       Impact factor: 6.531

8.  Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis.

Authors:  M Lebech; D H Joynson; H M Seitz; P Thulliez; R E Gilbert; G N Dutton; B Ovlisen; E Petersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

9.  Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak.

Authors:  A J Burnett; S G Shortt; J Isaac-Renton; A King; D Werker; W R Bowie
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

10.  Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.

Authors:  Antoine P Brézin; Philippe Thulliez; Jacques Couvreur; Roberto Nobré; Rima Mcleod; Marilyn B Mets
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

View more
  6 in total

1.  Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography.

Authors:  Juliana L Oréfice; Rogério A Costa; Fernando Oréfice; Wesley Campos; Décio da Costa-Lima; Ingrid U Scott
Journal:  Br J Ophthalmol       Date:  2006-11-29       Impact factor: 4.638

2.  Recovery of anti-Toxoplasma gondii immunoglobulin M in stored guthrie card blood spots.

Authors:  Hooi-Kuan Tan; Eskild Petersen; Lone N Møller; Pamela Phillips; Eurico Camargo Neto; Ruth E Gilbert
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

Review 3.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

4.  Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis.

Authors:  H Talabani; M Asseraf; H Yera; E Delair; T Ancelle; P Thulliez; A P Brézin; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

Review 5.  Immunological tests and their interpretation in uveitis.

Authors:  S R Rathinam; Ilknur Tugal-Tutkun; Mamta Agarwal; Vedhanayaki Rajesh; Merih Egriparmak; Gazal Patnaik
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

6.  Severe ocular sequelae of congenital toxoplasmosis: huge macular scar.

Authors:  Fadoua Zahir; Meriem Abdellaoui; Samar Younes; Idriss A Benatiya; Hicham Tahri
Journal:  Pan Afr Med J       Date:  2015-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.